Expression of interleukin-5 and tumor necrosis factor alpha in cervical carcinoma

Clinical and Vaccine Immunology

Volumn 16, Issue 6, 2009, Pages 959-961

  Dae, Woo Lee ^a   Young, Tae Kim ^a   Sang, Wun Kim ^a   Kim, SungHoon ^a   Jae, Hoon Kim ^a   Myung, Hwa Kang ^a   Jeong, Hye Hwang ^a   Jong, Baeck Lim ^a  

^a Yonsei University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 5; TUMOR MARKER; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; CANCER PATIENT; CARCINOMA IN SITU; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE MARKER; EOSINOPHIL COUNT; FEMALE; HUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; UTERINE CERVIX CARCINOMA; VAGINA SECRETION;

ADULT; FEMALE; HUMANS; INTERLEUKIN-5; MIDDLE AGED; TUMOR MARKERS, BIOLOGICAL; TUMOR NECROSIS FACTOR-ALPHA; UTERINE CERVICAL NEOPLASMS; VAGINA;

EID: 67249158869     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.00262-08     Document Type: Article

References (15)

1. Azar, K. K., M. Tani, H. Yasuda, A. Sakai, M. Inoue, and T. Sasagawa. 2004. Increased secretion patterns of interleukin-10 and tumor necrosis factor-alpha in cervical squamous intraepithelial lesions. Hum. Pathol. 35:1376-1384.
2. Bais, A. G., I. Beckmann, J. Lindemans, P. C. Ewing, C. J. Meijer, P. J. Snijders, and T. J. Helmerhorst. 2005. A shift to a peripheral Th2-type cytokine pattern during the carcinogenesis of cervical cancer becomes manifest in CIN III lesions. J. Clin. Pathol. 58:1096-1100.
3. Clerici, M., M. Merola, E. Ferrario, D. Trabattoni, M. L. Villa, B. Stefanon, D. J. Venzon, G. M. Shearer, G. De Palo, and E. Clerici. 1997. Cytokine production patterns in cervical intraepithelial neoplasia: association with human papillomavirus infection. J. Natl. Cancer Inst. 89:245-250.
4. Katz, V. L., G. Lentz, R. A. Lobo, and D. Gershenson. 2007. Comprehensive gynecology, 5th ed. Mosby Elsevier, Philadelphia, PA.
5. Mota, F., N. Rayment, S. Chong, A. Singer, and B. Chain. 1999. The antigen-presenting environment in normal and human papillomavirus (HPV)-related premalignant cervical epithelium. Clin. Exp. Immunol. 116:33-40.
6. Romagnani, S. 1991. Human TH1 and TH2 subsets: doubt no more. Immunol. Today 12:256-257.
7. Rothenberg, M. E., A. D. Luster, and P. Leder. 1995. Murine eotaxin: an eosinophil chemoattractant inducible in endothelial cells and in interleukin 4-induced tumor suppression. Proc. Natl. Acad. Sci. USA 92:8960-8964.
8. Scott, M., D. P. Stites, and A. B. Moscicki. 1999. Th1 cytokine patterns in cervical human papillomavirus infection. Clin. Diagn. Lab. Immunol. 6:751-755.
9. Sharma, A., M. Rajappa, A. Saxena, and M. Sharma. 2007. Cytokine profile in Indian women with cervical intraepithelial neoplasia and cancer cervix. Int. J. Gynecol. Cancer 17:879-885.
10. Simson, L., J. I. Ellyard, L. A. Dent., K. I. Matthaei, M. E. Rothenberg, P. S. Foster, M. J. Smyth, and C. R. Parish. 2007. Regulation of carcinogenesis by IL-5 and CCL11: a potential role for eosinophils in tumor immune surveillance. J. Immunol. 178:4222-4229. (Pubitemid 46492372)
11. Sun, C. A., H. C. Lai, C. C. Chang, S. Neih, C. P. Yu, and T. Y. Chu. 2001. The significance of human papillomavirus viral load in prediction of histologic severity and size of squamous intraepithelial lesions of uterine cervix. Gynecol. Oncol. 83:95-99.
12. Tjiong, M. Y., N. van der Vange, J. S. ter Schegget, M. P. Burger, F. W. ten Kate, and T. A. Out. 2001. Cytokines in cervicovaginal washing fluid from patients with cervical neoplasia. Cytokine 14:357-360.
13. van Driel, W. J., P. C. Hogendoorn, F. W. Jansen, A. H. Zwinderman, J. B. Trimbos, and G. J. Fleuren. 1996. Tumor-associated eosinophilic infiltrate of cervical cancer is indicative for a less effective immune response. Hum. Pathol. 27:904-911.
14. van Driel, W. J., P. Kievit-Tyson, L. C. van den Broek, A. H. Zwinderman, B. J. Trimbos, and G. J. Fleuren. 1999. Presence of an eosinophilic infiltrate in cervical squamous carcinoma results from a type 2 immune response. Gynecol. Oncol. 74:188-195.
15. Ylitalo, N., P. Sorensen, A. M. Josefsson, P. K. Magnusson, P. K. Andersen, J. Ponten, H. O. Adami, U. B. Gyllensten, and M. Melbye. 2000. Consistent high viral load of human papillomavirus 16 and risk of cervical carcinoma in situ: a nested case-control study. Lancet 355:2194-2198. (Pubitemid 30394326)